Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
PaperCitations, authors & open-access status
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 96 citations, 2021 year and bronze oa status.
96
Citations
2021
Year
bronze
OA Status